RxDoctor Payments Data

Christine Schonour, NP

Adult Health · Orchard Park, NYNPI 1285692483

Payments from drug & device makers

$1,967in general payments, 2019–2025

Across 115 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$435
  • Novo Nordisk$395
  • Amgen$236
  • Lilly USA, LLC$231
  • Amarin Pharma, Inc.$120
  • Boehringer Ingelheim$110
  • plus $441 from 13 others

What the payments were for

  • Food & beverage$1,967100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,967 in reported general payments places this provider in the 80th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$36,527
Medicare patients
163
Services billed
423

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban97$111,561
OzempicSemaglutide68$65,244
MounjaroTirzepatide39$39,153
JardianceEmpagliflozin24$29,973
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$29,192
TrulicityDulaglutide26$29,068
Breo ElliptaFluticasone/Vilanterol21$9,996
MyrbetriqMirabegron15$8,641
XareltoRivaroxaban11$6,465
Lantus SolostarInsulin Glargine,hum.Rec.Anlog45$5,910
Levothyroxine Sodium303$5,465
Atorvastatin Calcium421$5,430
Fluticasone-SalmeterolFluticasone Propion/Salmeterol34$4,670
Metoprolol Succinate199$4,605
Rosuvastatin Calcium287$4,185

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$231$68,22165 claims
Novo NordiskOzempic$395$65,24468 claims
GSKTrelegy Ellipta, Breo Ellipta$42$39,18855 claims
Boehringer IngelheimJardiance$110$29,97324 claims
AbbVieSynthroid$435$3,29340 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,828 adult health providers in New York.

Other adult health in Orchard Park

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →